{"favorite_id": 10276, "calc_type": "diagnostic_criteria", "dosing": false, "full_title_en": "Rome IV Diagnosis Criteria for Functional Heartburn", "short_title_en": "Rome IV for Heartburn", "medium_description_en": "Official Rome IV criteria for the diagnosis of functional heartburn.", "short_description_en": "Heartburn diagnosis.", "before_use": "", "instructions_en": "<p dir=\"ltr\">Use in patients with symptoms suggestive of functional heartburn, such as recurrent burning retrosternal discomfort or pain for at least 6 months, which is not responsive to antisecretory therapy.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional heartburn may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms suggestive of cardiac ischemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-8af6be34-7fff-760d-14a8-5a6a925ac134\"></p>", "purpose_en": ["Diagnosis"], "disease_en": ["Esophageal Disorders", "Disorders of Gut-Brain Interaction (DGBI)"], "specialty_en": ["Family Practice", "Gastroenterology", "Hospitalist Medicine", "Internal Medicine", "Primary Care"], "chief_complaint_en": ["Heartburn"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Rome IV Criteria for Functional Heartburn, Rome IV for Heartburn, rome iv heartburn, rome iv for functional heartburn, rome iv heartburn, rome 4 functional heartburn, rome 4 heartburn, rome 4 criteria for functional heartburn, rome 4 for heartburn, rome iv, rome 4, heartburn, rome iv criteria, functional heartburn, functional heartburn diagnosis, heartburn diagnosis, rome heartburn"], "slug": "rome-iv-diagnosis-criteria-functional-heartburn", "seo": {"meta_description_en": "The Rome IV Criteria for Functional Heartburn provides criteria for diagnosis of functional heartburn.", "keywords_en": "Rome IV Criteria for Functional Heartburn, Rome IV for Heartburn, rome iv heartburn, rome iv for functional heartburn, rome iv heartburn, rome 4 functional heartburn, rome 4 heartburn, rome 4 criteria for functional heartburn, rome 4 for heartburn, rome iv, rome 4, heartburn, rome iv criteria, rome 4 for functional heartburn, functional heartburn, functional heartburn diagnosis, heartburn diagnosis,  rome iv reflux hypersensitivity, rome iv globus, rome iv functional dysphagia, rome iv functional chest pain, rome heartburn"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-98b9994b-7fff-2016-6d0a-5b4677766e2d\">Patients presenting with recurrent retrosternal discomfort or pain for at least the past 6 months which are suggestive of functional heartburn. The diagnosis of functional heartburn should be made only after cardiac disease, gastroesophageal reflux disease, eosinophilic esophagitis, and major esophageal motility disorders have been excluded.</p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-ab1cb266-7fff-68b5-cfbe-3d860f9c9ec7\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">By definition, patients with functional heartburn do not experience relief of symptoms with optimal antisecretory therapy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Ambulatory reflux monitoring should be considered in patients without macroscopic evidence of gastroesophageal reflux disease (GERD) on upper endoscopy. Absence of abnormal acid exposure and symptom reflux association on pH testing is supportive of a diagnosis of functional heartburn.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If esophageal manometry is performed, identification of a major esophageal motility disorder (e.g. achalasia, EGJ outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, absent peristalsis) may explain the symptoms or coexist with functional heartburn.</p>\n</li>\n</ul>", "why_use_en": "<p><span id=\"docs-internal-guid-13b65219-7fff-9963-2a6d-6f37d3bed656\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Helps to make a diagnosis of functional heartburn when appropriate workup, including assessment for pathologic GERD (pH study), eosinophilic esophagitis, and major esophageal motility disorders, is nondiagnostic.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Helps to distinguish symptoms from other common disorders, such as GERD.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Helps to guide management of symptoms once a diagnosis of functional heartburn is established.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p dir=\"ltr\"><strong>If diagnostic criteria are not met (negative):</strong></p>\n<p dir=\"ltr\">Symptoms are unlikely to be caused by functional heartburn. Consider further assessment for other diseases, or a different functional GI disorder.</p>\n<p dir=\"ltr\"><strong>If meets diagnosis (positive):</strong></p>\n<p><span id=\"docs-internal-guid-70dafe82-7fff-ce3c-009d-3c8b0714fa92\">Likely diagnosis of functional heartburn. Consider management as per current <a href=\"https://www.gastrojournal.org/article/S0016-5085(20)30128-1/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F32017911%2F\" target=\"_blank\" rel=\"noopener\">American Gastroenterological Association (AGA)</a>&nbsp;Clinical Practice Update.</p>", "management_en": "<p dir=\"ltr\">Management of functional heartburn may include:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Tricyclic antidepressants (TCAs).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Selective serotonin reuptake inhibitors (SSRIs).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Serotonin noradrenergic reuptake inhibitors (SNRIs).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Behavioral therapy (i.e. hypnosis).</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-22058271-7fff-b4e5-604b-0768abe4afdb\">Consult <a href=\"https://www.gastrojournal.org/article/S0016-5085(20)30128-1/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F32017911%2F\" target=\"_blank\" rel=\"noopener\">AGA guidelines</a> for further details.</p>", "critical_actions_en": "<p><span id=\"docs-internal-guid-58a1aff0-7fff-2f2d-26ff-beaabe255f35\">This calculator should only be used in patients who do not have signs or symptoms suggestive of a structural/mechanical, metabolic or systemic cause of their symptoms based on clinical history, physical exam and initial work-up. An esophageal pH study must show a normal amount of acid reflux and no symptom association with acid reflux. </p>"}, "about": {"formula_en": "<p dir=\"ltr\">To fulfill the Rome IV criteria for functional heartburn, patient must have the following (for 3 months prior with symptom onset &ge;6 months ago with a frequency of at least twice a week):</p>\n<ol>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Burning retrosternal discomfort or pain.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">No symptom relief despite optimal antisecretory therapy.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Absence of evidence that gastroesophageal reflux (abnormal acid exposure and symptom reflux association) or <abbr title=\"Eosinophilic esophagitis\">EOE</abbr> is the cause of symptoms.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Absence of major esophageal motor disorders (achalasia/<abbr title=\"Esophagogastric junction\">EGJ</abbr> outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, absent peristalsis).</p>\n</li>\n</ol>", "more_info_en": "", "evidence_based_medicine_en": "<p dir=\"ltr\">The Rome criteria were initially developed as a way to classify and diagnose the various disorders of gut brain interaction (DGBI) such as functional dyspepsia, functional constipation, and irritable bowel syndrome (IBS) based primarily on symptoms.</p>\n<p><span id=\"docs-internal-guid-eda9043a-7fff-3eba-f648-92e10f90f2b6\">The development of the Rome IV questionnaires began with a survey of 1,162 adults without gastrointestinal disorders to determine the frequency in the US general population of various gastrointestinal symptoms. The 90<sup>th</sup> percentile of symptom frequency was used to define what was considered an abnormal frequency of symptoms. Based on this, diagnostic questionnaires were created and reviewed by clinical experts.</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/27144625", "text": "Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology. 2016;150:1368-1379."}], "Other References": [{"href": "https://pubmed.ncbi.nlm.nih.gov/32017911", "text": "Fass R, Zerbib F, Gyawali CP. AGA Clinical Practice Update on Functional Heartburn: Expert Review. Gastroenterology. 2020;158(8):2286-2293."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/28711175", "text": "Mahoney LB, Nurko S, Rosen R. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children. J Pediatr. 2017;189:86-91."}, {"href": "https://pubmed.ncbi.nlm.nih.gov/30574316/", "text": "Josefsson A, Palsson O, Simr\u00e9n M, Sperber AD, T\u00f6rnblom H, Whitehead W. Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population. United European Gastroenterol J. 2018;6(10):1461-1469."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "", "firstName": "David", "img": "", "lastName": "Cangemi", "name": "David Cangemi, MD", "target": "", "signedCOI": false, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Douglas Drossman", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Douglas Drossman, MD, is professor emeritus of medicine and psychiatry at the University of North Carolina School of Medicine. He is founder, President Emeritus and Chief of Operations of the Rome Foundation. He is also the founder of the Drossman Center for the Education and Practice of Biopsychosocial Care and Drossman Consulting, LLC. Dr. Drossman has written over 500 articles and book chapters, has published two books, a GI procedure manual and a textbook of functional GI disorders (Rome I-IV), and serves on six editorial and advisory boards.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-douglas-drossman.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Drossman+DA%5BAuthor%5D"}}, {"name": "Dr. Lin Chang", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Lin Chang, MD is responsible for the oversight and coordination of the Rome IV calculators on MDCalc. She is a Professor of Medicine at the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA and is a member of the Rome Foundation Board of Directors.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lin-chang.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Chang+L+%5Bauthor%5D"}}, {"name": "The Rome Foundation", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>The <a href=\"https://theromefoundation.org\" target=\"_blank\" rel=\"noopener\">Rome Foundation</a> is an independent not for profit 501(c) 3 organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of Disorders of Gut-Brain Interaction (DGBI), also known as functional gastrointestinal (GI) disorders. Their mission is to improve the lives of people with DGBI. Over the last 3 decades, the Rome organization has sought to legitimize and update our knowledge of the DGBIs. This has been accomplished by bringing together scientists and clinicians from around the world to classify and critically appraise the science of GI function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice. Diagnosis is based on the use of <a href=\"https://theromefoundation.org/rome-iv/rome-iv-criteria/\" target=\"_blank\" rel=\"noopener\">symptom-based criteria</a> which are used in clinical trials and daily practice. The list of Rome IV categories and the Chair and Co-Chair of each chapter committee are listed below.</p>\n<table border=\"\\&quot;0\\&quot;\" collapse;=\"\" width:=\"\" 100%;\\\"=\"\">\n<tbody>\n<tr>\n<td 31.1628%;\\\"=\"\"><strong>Committees</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Chair</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Co-Chair</strong></td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Esophageal Disorders</td>\n<td 31.3097%;\\\"=\"\">Ronnie Fass, MD</td>\n<td 31.3097%;\\\"=\"\">John Pandolfino, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gastroduodenal Disorders</td>\n<td 31.3097%;\\\"=\"\">Nicholas J. Talley, MD, PhD, FRACP</td>\n<td 31.3097%;\\\"=\"\">Vincenzo Stanghellini, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Bowel Disorders</td>\n<td 31.3097%;\\\"=\"\">Fermin Mearin, MD</td>\n<td 31.3097%;\\\"=\"\">Brian Lacy, MD, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gallbladder and Sphincter of Oddi Disorders</td>\n<td 31.3097%;\\\"=\"\">Grace Elta, MD</td>\n<td 31.3097%;\\\"=\"\">Peter Cotton, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Centrally Mediated Disorders of Gastrointestinal Pain</td>\n<td 31.3097%;\\\"=\"\">Peter J. Whorwell, MD</td>\n<td 31.3097%;\\\"=\"\">Laurie Keefer, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Anorectal Disorders</td>\n<td 31.3097%;\\\"=\"\">Adil E. Bharucha, MD, MBBS</td>\n<td 31.3097%;\\\"=\"\">Satish S. C. Rao, MD, PhD, FRCP</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Neonate/Toddler</td>\n<td 31.3097%;\\\"=\"\">Sam Nurko, MD</td>\n<td 31.3097%;\\\"=\"\">Marc A. Benninga, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Child/Adolescent</td>\n<td 31.3097%;\\\"=\"\">Carlo Di Lorenzo, MD</td>\n<td 31.3097%;\\\"=\"\">Jeffrey S. Hyams, MD</td>\n</tr>\n</tbody>\n</table>\n<p><b>Rome IV Diagnostic Criteria Chapters, Chairs and Co-Chairs</b></p>\n<p><b>Rome IV Editorial Board:</b> Douglas A. Drossman, MD, Senior Editor, Lin Chang, MD, William D. Chey, MD, John Kellow, MD, Jan Tack, MD, PhD, and William E. Whitehead, PhD.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/rome-foundation.png", "pubmedLink": "undefined"}}], "reviewer": {"expert_name": [{"name": "Jan Track, MD, PhD, RFF"}, {"name": "William D. Chey, MD, AGAF, FACG, FACP"}]}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "Must have the following:", "subheading_instructions": "For 3 months prior with symptom onset \u22656 months ago with a frequency of at least twice a week", "type": "subheading"}, {"type": "toggle", "label_en": "Burning retrosternal discomfort or pain", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "one"}, {"type": "toggle", "label_en": "No symptom relief despite optimal antisecretory therapy", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "two"}, {"type": "toggle", "label_en": "Absence of evidence that gastroesophageal reflux (abnormal acid exposure and symptom reflux association) or <abbr title=\"Eosinophilic esophagitis\">EOE</abbr> is the cause of symptoms", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "three"}, {"type": "toggle", "label_en": "Absence of major esophageal motor disorders (achalasia/<abbr title=\"Esophagogastric junction\">EGJ</abbr> outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, absent peristalsis)", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "four"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 10275, "short_title_en": "Rome IV for Chest Pain", "slug": "rome-iv-diagnostic-criteria-functional-chest-pain"}, {"calcId": 10283, "short_title_en": "Rome IV for Functional Dysphagia", "slug": "rome-iv-diagnostic-criteria-functional-dysphagia"}, {"calcId": 10315, "short_title_en": "Rome IV for Infant Diarrhea", "slug": "rome-iv-diagnostic-criteria-infant-functional-diarrhea"}]}